For instance, pseudogenes DUXAP8, MST O 2P and MYLKP1 involved in supporting CRC progression and enhance cancer risk (Lynn et al., 2018; He et al., 2020; Guo and Zhang, 2022). This evidence concerns the gene MYLKP1 and colorectal carcinoma.